Novo Nordisk A/S (NVO) Deep Dive Video

Novo Nordisk remains a world-class metabolic disease pioneer, but its next five years hinge on converting oral Wegovy demand and manufacturing scale into durable growth while defending margins against Lilly, PBMs, Medicare and generics.